SCHEMBL6161190

SCHEMBL6161190

COc1ccccc1OCC1CNCCO1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRA2C P18825 1/20 1.00
▸ SLC6A4 P31645 5/20 0.80
▸ HTR2A P28223 4/20 0.80
▸ SLC6A2 P23975 3/20 0.80
▸ SLC6A3 Q01959 3/20 0.80
▸ HTR2B P41595 2/20 0.80
▸ ADRB2 P07550 1/20 0.80
▸ HTR1A P08908 1/20 0.80
▸ ADRA1A P35348 1/20 0.80
▸ HRH1 P35367 1/20 0.58
▸ OPRD1 P41143 1/20 0.58
▸ OPRK1 P41145 1/20 0.58
▸ HTR3A P46098 1/20 0.58
▸ DRD4 P21917 2/20 0.52
▸ EPHA2 P29317 5/20 0.51
▸ CYP1A2 P05177 1/20 0.49
▸ CYP3A4 P08684 1/20 0.49
▸ HTR1D P28221 1/20 0.49
▸ HTR1B P28222 1/20 0.49
▸ CHRNB4 P30926 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3195832 0.91 ADRA2C (0.82) ADRA2CSLC6A4HTR2ASLC6A2SLC6A3
(R)-Viloxazine SCHEMBL2524727 0.89 SLC6A4 (1.00) ADRA2CSLC6A4HTR2ASLC6A2SLC6A3
(S)-Viloxazine SCHEMBL31126415 0.89 SLC6A4 (1.00) ADRA2CSLC6A4HTR2ASLC6A2SLC6A3
Viloxazine SCHEMBL34168 0.89 SLC6A4 (1.00) ADRA2CSLC6A4HTR2ASLC6A2SLC6A3
(S)-Viloxazine SCHEMBL2524730 0.89 SLC6A4 (1.00) ADRA2CSLC6A4HTR2ASLC6A2SLC6A3
Viloxazine SCHEMBL29359040 0.89 SLC6A4 (1.00) ADRA2CSLC6A4HTR2ASLC6A2SLC6A3
(R)-Viloxazine SCHEMBL30589854 0.89 SLC6A4 (1.00) ADRA2CSLC6A4HTR2ASLC6A2SLC6A3
(S)-Viloxazine SCHEMBL25394508 0.87 SLC6A4 (0.97) ADRA2CSLC6A4HTR2ASLC6A2SLC6A3
Viloxazine SCHEMBL300741 0.87 SLC6A4 (0.97) ADRA2CSLC6A4HTR2ASLC6A2SLC6A3
Viloxazine SCHEMBL29362568 0.87 SLC6A4 (0.97) ADRA2CSLC6A4HTR2ASLC6A2SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0920423-B1 DISUBSTITUTED MORPHOLINE, OXAZEPINE OR THIAZEPINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS DOPAMINE D4 RECEPTOR ANTAGONISTS NEUROSEARCH AS (DK) 2005-01-26 — — EP disclosed
US-6479491-B1 USEFUL IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, ESPECIALLY PSYCHOTIC DISORDERS SUCH AS SCHIZOPHRENIA NEUROSEARCH A/S (DK) 2002-11-12 — — US disclosed
US-6207662-B1 USEFUL IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, PSYCHOTIC DISORDERS SUCH AS SCHIZOPHRENIA NEUROSEARCH A/S (DK) 2001-03-27 — — US disclosed
EP-0920423-A1 DISUBSTITUTED MORPHOLINE, OXAZEPINE OR THIAZEPINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS DOPAMINE D4 RECEPTOR ANTAGONISTS NEUROSEARCH A/S (DK) 1999-06-09 — — EP disclosed
WO-1998007710-A1 DISUBSTITUTED MORPHOLINE, OXAZEPINE OR THIAZEPINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS DOPAMINE D4 RECEPTOR ANTAGONISTS NEUROSEARCH A/S (DK) 1998-02-26 — — WO disclosed
Send feedback